In 2023, Montefiore Einstein Comprehensive Cancer Center marked a significant milestone as the sole provider of CAR T-cell therapy for pediatric patients in the Bronx. This groundbreaking therapy, pivotal in treating various blood cancers, has been a beacon of hope for children battling cancer in our community. Our center's unique position in offering this advanced treatment underscores our commitment to pediatric oncology care. By harnessing the power of a patient’s own immune system, CAR T-cell therapy has revolutionized the approach to cancer treatment, especially for our youngest patients facing some of the most challenging diagnoses.

Recent achievements in CAR T-cell therapy at Montefiore Einstein have been particularly noteworthy. Not only have we provided cutting-edge treatment options for children with cancer, but our institution has also been at the forefront of research and development in this area. Our clinical trials and research initiatives continue to push the boundaries of medical science, aiming to extend the benefits of this innovative therapy to a broader range of cancers. The success of these efforts reflects our unwavering dedication to pediatric cancer care and our relentless pursuit of treatment advancements that can change the lives of our patients in the Bronx and beyond.